SUBSCRIBE
SUBSCRIBE
News   Deals

Express Scripts Inc. Closes Wellpoint Drug Unit Deal

December 1, 2009 | 
1 min read
Bookmark and Share

Reuters -- Express Scripts Inc said on Tuesday it closed its $4.68 billion acquisition of WellPoint Inc's (WLP.N) drug benefit business, and WellPoint said it would record a large fourth-quarter gain from the sale.
Mergers & acquisitions
MORE ON THIS TOPIC
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
shopping cart loaded with pills with dollar signs around it on a light blue background
Earnings
Novartis Sticks With M&A Strategy of Building Early Pipeline, Searching for Near-Launches
February 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company
Earnings
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline
February 3, 2026
 · 
2 min read
 · 
Dan Samorodnitsky
Roche's tower in Shanghai, China
Deals
Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
February 3, 2026
 · 
1 min read
 · 
Tristan Manalac